Clin Exp Rheum 41(6):1323-1331, 2023
FDA Restrictions on Compound GLP-1 Medications This regulatory action follows the FDA's February 2025 declaration that the semaglutide shortage is officially "resolved." For compounded tirzepatide (Zepbound), the deadline was earlier - March 2025
## Choosing Between GLP-1 Medications: What the Clinical Data Actually Shows If you have spent any time researching weight loss medications, you have probably encountered a confusing alphabet soup: GLP-1, GIP, Semaglutide, Tirzepatide, Retatrutide
A recent study suggests that among individuals with LDL cholesterol 190 mg/dl, gene sequencing identified a monogenic FH mutation in only 100 mg/dL (455)
For a 5mg/ml concentration, here is every standard dose converted to both milliliters and insulin syringe units